Atlas Trials

Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL

Clinical trial NCT00319930 · TERMINATED

Trial details

NCT number
NCT00319930
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2005-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.